Curated Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Curated Wealth Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	+25,495	New	+$2.14M	0.02%	579

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Curated Wealth Partners's EW Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Edwards Lifesciences (EW) in Q2 2026: 25,495 shares worth $120K. The stake represents 0.02% of the portfolio and ranks #579 among its holdings.

458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Curated Wealth Partners held 25,495 shares of Edwards Lifesciences worth $120K as of Q2 2026.
Edwards Lifesciences was a new Curated Wealth Partners position in Q2 2026.
Edwards Lifesciences made up 0.02% of Curated Wealth Partners's portfolio in Q2 2026, its #579 holding.
458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.